US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
AU2515992A
(en)
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
EP0641781B1
(en)
|
1991-09-06 |
2000-07-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
EXPRESSION OF HUMAN INTERLEUKIN-1-g(b) IN A TRANSGENIC ANIMAL
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
SI0956865T2
(en)
|
1996-08-12 |
2011-04-29 |
Mitsubishi Pharma Corp |
MEDICINES COMPRISING Rho KINASE INHIBITOR
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
EP0981352B8
(en)
|
1997-05-07 |
2009-06-17 |
Pharma Mar, S.A. |
Use of aplidine for the treatment of cardiovascular diseases
|
CA2292339A1
(en)
|
1997-06-13 |
1998-12-17 |
Ludwig Institute For Cancer Research |
Smad6 and uses thereof
|
WO1999001426A1
(en)
|
1997-07-01 |
1999-01-14 |
Warner-Lambert Company |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
AU773012B2
(en)
|
1998-07-24 |
2004-05-13 |
Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the TGF-beta family of growth factors
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
AU2483000A
(en)
|
1999-01-07 |
2000-07-24 |
Warner-Lambert Company |
Treatment of asthma with mek inhibitors
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
WO2000078351A1
(en)
|
1999-06-18 |
2000-12-28 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
AU6865100A
(en)
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
AU2001273498B2
(en)
|
2000-07-19 |
2006-08-24 |
Warner-Lambert Company |
Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
|
AU2002245709A1
(en)
|
2001-03-23 |
2002-10-08 |
Bayer Corporation |
Rho-kinase inhibitors
|
AR035791A1
(en)
|
2001-03-23 |
2004-07-14 |
Bayer Corp |
COMPOUND N, N-DIHETEROCICLICO OF AMINA, INHIBITOR OF THE RHO-KINASE, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS FOR THE PREPARATION OF THE COMPOUND
|
EP1385946B1
(en)
|
2001-05-01 |
2009-12-23 |
National Research Council Of Canada |
A system for inducible expression in eukaryotic cells
|
AU2002330465B2
(en)
|
2001-09-21 |
2006-07-27 |
Kyoto University |
Screening method for a reprogramming agent, reprogramming agent screened by the method, method for using the reprogramming agent, method for differentiating an undifferentiated fusion cell, and production method of cells, tissues and organs.
|
ATE554169T1
(en)
|
2001-11-02 |
2012-05-15 |
Giuliani Int Ltd |
SMAD7 INHIBITORS FOR THE TREATMENT OF CNS DISEASES
|
AU2003202263A1
(en)
|
2002-01-10 |
2003-07-30 |
Bayer Healthcare Ag |
Roh-kinase inhibitors
|
US6943172B2
(en)
|
2002-01-23 |
2005-09-13 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
CA2473510A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
WO2003073843A2
(en)
|
2002-03-05 |
2003-09-12 |
Artemis Pharmaceuticals Gmbh |
Inbred embryonic stem-cell derived mice
|
SG148857A1
(en)
|
2002-03-13 |
2009-01-29 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
AU2003220935A1
(en)
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Company, Limited. |
Benzamide derivatives
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
EP1562935B1
(en)
|
2002-10-28 |
2006-09-06 |
Bayer HealthCare AG |
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
|
WO2004045617A1
(en)
|
2002-11-15 |
2004-06-03 |
Warner-Lambert Company Llc |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
JP2006517234A
(en)
|
2003-02-10 |
2006-07-20 |
アムジエン・インコーポレーテツド |
Vanilloid receptor ligands and their use in therapy
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
WO2005084158A2
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
US7727762B2
(en)
|
2003-10-03 |
2010-06-01 |
Keiichi Fukuda |
Method of inducing the differentiation of stem cells into myocardial cells
|
JP4110324B2
(en)
|
2003-10-15 |
2008-07-02 |
宇部興産株式会社 |
New indazole derivatives
|
WO2005038010A2
(en)
|
2003-10-16 |
2005-04-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
AU2004291559B2
(en)
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
AU2004293019B2
(en)
|
2003-11-19 |
2010-10-28 |
Array Biopharma Inc. |
Bicyclic inhibitors of MEK and methods of use thereof
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
EP1713775A4
(en)
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
Chemical compounds
|
AU2005241009A1
(en)
|
2004-04-21 |
2005-11-17 |
Mcmaster University |
Myosin light chain kinase inhibitors and their use
|
EP1791952A4
(en)
|
2004-08-13 |
2008-06-11 |
Univ Georgia Res Found |
Compositions and methods for self-renewal and differentiation in human embryonic stem cells
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
US20060182724A1
(en)
|
2005-02-15 |
2006-08-17 |
Riordan Neil H |
Method for expansion of stem cells
|
TWI441637B
(en)
|
2005-05-18 |
2014-06-21 |
Array Biopharma Inc |
Heterocyclic inhibitors of mek and methods of use thereof
|
CN101313065A
(en)
|
2005-08-01 |
2008-11-26 |
纽珀滕索有限公司 |
Production of reprogrammed cells with restored potential
|
CA2621161A1
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
EP4223769A3
(en)
|
2005-12-13 |
2023-11-01 |
Kyoto University |
Nuclear reprogramming factor
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
JPWO2007088651A1
(en)
|
2006-02-01 |
2009-06-25 |
国立大学法人 東京大学 |
Combination use of TGF-β signal inhibitor and antitumor agent
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
EP1999249B8
(en)
|
2006-03-30 |
2012-02-15 |
The University Court Of The University of Edinburgh |
Culture medium containing kinase inhibitors. and uses thereof
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
US20070259423A1
(en)
|
2006-05-02 |
2007-11-08 |
Jon Odorico |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
CA2656398A1
(en)
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Substituted piperidines that increase p53 activity and the uses thereof
|
JP4960450B2
(en)
|
2006-07-14 |
2012-06-27 |
ノバルティス アーゲー |
Pyrimidine derivatives as ALK-5 inhibitors
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
JP2008099662A
(en)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
Method for culturing stem cell
|
ZA200901914B
(en)
|
2006-09-22 |
2010-06-30 |
Riken |
Stem cell culture medium and method
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
JP5419279B2
(en)
|
2007-01-17 |
2014-02-19 |
ウィスコンシン アラムニ リサーチ ファンデーション |
Improved stem cell culture
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
CN101641436A
(en)
|
2007-01-30 |
2010-02-03 |
佐治亚大学研究基金会 |
Be used to produce the promptly stable mesendoderm cell mass of early stage mesoblastema of entoderm and mesoblastema system and multipotency wandering cell (MMC)
|
WO2008105630A1
(en)
|
2007-02-27 |
2008-09-04 |
Procell Therapeutics Inc. |
Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
EP2131840B1
(en)
|
2007-03-07 |
2018-10-17 |
MEI Pharma, Inc. |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
CN103555654B
(en)
|
2007-04-18 |
2016-04-20 |
哈达锡特医学研究服务及发展有限公司 |
Stem cell-derived retinal pigment epithelium
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
JP2008307007A
(en)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
DK2173863T3
(en)
|
2007-06-29 |
2019-01-21 |
Fujifilm Cellular Dynamics Inc |
Automated method and apparatus for embryonic stem cell culture
|
WO2009032456A2
(en)
|
2007-08-01 |
2009-03-12 |
Primegen Biotech Llc |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
MX2010002242A
(en)
|
2007-08-31 |
2010-06-01 |
Whitehead Biomedical Inst |
Wnt pathway stimulation in reprogramming somatic cells.
|
WO2009057831A1
(en)
|
2007-10-31 |
2009-05-07 |
Kyoto University |
Nuclear reprogramming method
|
WO2009061442A1
(en)
|
2007-11-06 |
2009-05-14 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells
|
JP4604076B2
(en)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
Electrolyte membrane for fuel cell
|
WO2009073523A2
(en)
|
2007-11-29 |
2009-06-11 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
EP2227241A1
(en)
|
2007-11-30 |
2010-09-15 |
Cytomatrix PTY LTD |
Methods of inducing pluripotency involving sox2 protein
|
US20110190730A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving oct4 protein
|
CN102027105B
(en)
|
2008-03-17 |
2015-03-11 |
斯克里普斯研究所 |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
EP2268796A1
(en)
|
2008-03-17 |
2011-01-05 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
|
CN101550406B
(en)
|
2008-04-03 |
2016-02-10 |
北京大学 |
Prepare the method for pluripotent stem cell, test kit and purposes
|
CN107012123A
(en)
*
|
2008-07-30 |
2017-08-04 |
国立大学法人京都大学 |
The method for effectively setting up the multipotential stem cell of induction
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
WO2010053472A1
(en)
|
2008-11-04 |
2010-05-14 |
Novocell, Inc. |
Stem cell aggregate suspension compositions and methods for differentiation thereof
|
SG196784A1
(en)
|
2008-12-03 |
2014-02-13 |
Scripps Research Inst |
Stem cell cultures
|
US8906677B2
(en)
|
2008-12-17 |
2014-12-09 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
CN102395672A
(en)
|
2009-04-13 |
2012-03-28 |
加利福尼亚大学董事会 |
Methods and compositions for stem cell cultures
|
AU2010253844A1
(en)
|
2009-05-27 |
2012-02-02 |
Center Of Regenerative Medicine Of Barcelona, Spain |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
US9005975B2
(en)
|
2009-05-29 |
2015-04-14 |
Kyoto University |
Method for selecting clone of induced pluripotent stem cells
|
ES2726766T3
(en)
|
2009-08-07 |
2019-10-09 |
Univ Kyoto |
Method for the efficient development of induced pluripotent stem cells
|
ES2938049T3
(en)
|
2009-10-16 |
2023-04-04 |
Scripps Research Inst |
Induction of stem cells
|
US9528087B2
(en)
|
2009-10-31 |
2016-12-27 |
Genesis Technologies Limited |
Methods for reprogramming cells and uses thereof
|
CA2777710C
(en)
|
2009-11-04 |
2021-02-23 |
Cellular Dynamics International, Inc. |
Episomal reprogramming with chemicals
|
WO2011058558A2
(en)
|
2009-11-12 |
2011-05-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
JP5827220B2
(en)
*
|
2010-01-22 |
2015-12-02 |
国立大学法人京都大学 |
Method for improving the efficiency of establishment of induced pluripotent stem cells
|
WO2011103343A2
(en)
|
2010-02-17 |
2011-08-25 |
Biotime Inc. |
Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
|
ES2533581T3
(en)
|
2010-03-05 |
2015-04-13 |
Texas Heart Institute |
ETS2 and Mesp1 generators of cardiac progenitors from fibroblasts
|
CA2800498C
(en)
|
2010-03-31 |
2021-11-16 |
The Scripps Research Institute |
Reprogramming cells
|
WO2011158852A1
(en)
|
2010-06-15 |
2011-12-22 |
国立大学法人東京大学 |
Process for production of induced pluripotent stem cell
|
ES2670842T3
(en)
|
2010-06-15 |
2018-06-01 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
EP2601289B1
(en)
|
2010-08-04 |
2017-07-12 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
CN114164167A
(en)
|
2010-12-22 |
2022-03-11 |
菲特治疗公司 |
Cell culture platform for single cell sorting and enhanced IPSC reprogramming
|
US9458131B2
(en)
*
|
2011-11-08 |
2016-10-04 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
AU2012347534B2
(en)
|
2011-12-08 |
2018-01-25 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
WO2013159103A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
WO2013176197A1
(en)
|
2012-05-22 |
2013-11-28 |
国立大学法人 東京大学 |
Method for producing antigen-specific t cells
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
SG11201606934SA
(en)
|
2014-03-04 |
2016-09-29 |
Fate Therapeutics Inc |
Improved reprogramming methods and cell culture platforms
|
CN117737124A
(en)
|
2015-10-16 |
2024-03-22 |
菲特治疗公司 |
Platform for inducing and maintaining ground state pluripotency
|
AU2016349504B2
(en)
|
2015-11-04 |
2023-02-09 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|